Germany’s BioNTech to build Africa vaccine plant from 2022

Swiss authorise COVID booster jabs for the vulnerable
26 October 2021
Italy likely to offer anti-COVID boosters to entire population
26 October 2021

Germany’s BioNTech to build Africa vaccine plant from 2022

Germany’s BioNTech, which developed a coronavirus vaccine with US pharmaceutical giant Pfizer, said Tuesday it aims to begin building a vaccine plant in Africa next year.

Comments are closed.